MIMEDX GROUP INC
MDXGNASDAQ🏆 #2240 by market capUS Equity
$623.00▼ $36.45 (−5.85%)
Simulated price1h—
24h▼ 5.8%
7d—
14d—
30d—
1y—
🏦Market Cap
$630M
Small Cap
📈Revenue Growth (YoY)
-2.4%
Declining
📊Gross Margin
78.8%
High
💵FCF Margin
19.5%
Healthy
⚖️P/S Ratio
1.8x
Cheap
Otter Score
46
Weak
No chart data available for MDXG.
Trading Snapshot
- Day Range
- $617.85 – $627.41
- 52-Week Range
- $3.03 – $7.97
- Volume
- $3.68B
- Avg Volume
- $3.45B
- Shares Outstanding
- 145.8M
- Next Earnings
- Oct 19, 2026
Fundamentals Snapshot
- Annual Revenue
- $359M
- Last Q Revenue
- $88M
- P/E Ratio
- 99.8
- P/S Ratio
- 1.8x
- EPS (TTM)
- $0.04
- Dividend Yield
- —
Why Investors Own MDXG
- ✓High-growth profile — revenue up +5.8% YoY with expanding US Equity exposure.
- ✓Healthy economics — 62% gross margin and 16% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$359M▲ +1.5% YoY
Gross Margin (TTM)
62.4%▲ +2.7% YoY
Operating Income (TTM)
$42M▲ +1.5% YoY
Free Cash Flow (TTM)
$59M▲ +1.5% YoY
About MIMEDX GROUP INC
A company profile for MIMEDX GROUP INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
46/100
Analyst Price Target
ⓘAverage Target
$615.42
▼ −1.2% Downside
High Target$732.94
Low Target$546.30
Based on 17 analysts
Latest News & Updates
🚀
CNBC·2h ago
MIMEDX GROUP INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Bloomberg·5h ago
Analysts lift MDXG price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Bloomberg·1d ago
MIMEDX GROUP INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.